In vitro sensitivity of hematopoietic progenitors to Tiazofurin in refractory acute myeloid leukemia and in the blast crisis of chronic myeloid leukemiaCOLOVIC, M; SEFER, D; BOGDANOVIC, A et al.Cancer letters. 2003, Vol 195, Num 2, pp 153-159, issn 0304-3835, 7 p.Article

Novel strategies for relapsed and refractory acute myeloid leukemiaMATO, Anthony R; MORGANS, Alicia; LUGER, Selina M et al.Current opinion in hematology. 2008, Vol 15, Num 2, pp 108-114, issn 1065-6251, 7 p.Article

Remission induction in acute myeloid leukemia : PIH: How to improve the outcome of adult acute myeloid leukemia?STEIN, Eytan M; TALLMAN, Martin S.International journal of hematology. 2012, Vol 96, Num 2, pp 164-170, issn 0925-5710, 7 p.Article

Telomerase activity is prognostic in pediatric patients with acute myeloid leukemia: Comparison with adult acute myeloid leukemiaVERSTOVSEK, Srdan; MANSHOURI, Taghi; SMITH, Franklin O et al.Cancer. 2003, Vol 97, Num 9, pp 2212-2217, issn 0008-543X, 6 p.Article

ELA2 is regulated by hematopoietic transcription factors, but not repressed by AML1-ETOLAUSEN, J; LIU, S; FLIEGAUF, M et al.Oncogene (Basingstoke). 2006, Vol 25, Num 9, pp 1349-1357, issn 0950-9232, 9 p.Article

Comparative proteome analysis of acute myeloid leukemia with and without maturationLUCZAK, Magdalena; KAZMIERCZAK, Maciej; HANDSCHUH, Luiza et al.Journal of proteomics (Print). 2012, Vol 75, Num 18, pp 5734-5748, issn 1874-3919, 15 p.Article

Drastic effect of cell density on the cytotoxicity of daunorubicin and cytosine arabinosideMASQUELIER, Michèle; VITOLS, Sigurd.Biochemical pharmacology. 2004, Vol 67, Num 9, pp 1639-1646, issn 0006-2952, 8 p.Article

Cytotoxic activity to acute myeloid leukemia cells by Antp-TPR hybrid peptide targeting Hsp90HORIBE, Tomohisa; KAWAMOTO, Megumi; KOHNO, Masayuki et al.Journal of bioscience and bioengineering. 2012, Vol 114, Num 1, pp 96-103, issn 1389-1723, 8 p.Article

Drug treatment in the development of mismatch repair defective acute leukemia and myelodysplastic syndromeCASORELLI, Ida; OFFMAN, Judith; MELE, Luca et al.DNA repair. 2003, Vol 2, Num 5, pp 547-559, issn 1568-7864, 13 p.Article

IDH mutations in acute myeloid leukemiaRAKHEJA, Dinesh; KONOPLEV, Sergej; MEDEIROS, L. Jeffrey et al.Human pathology. 2012, Vol 43, Num 10, pp 1541-1551, issn 0046-8177, 11 p.Article

Acute myeloid leukemia with pseudo-chédiak-higashi anomaly exhibits a specific immunophenotype with CD2 expressionHONG CHANG; QI LONG YI.American journal of clinical pathology. 2006, Vol 125, Num 5, pp 791-794, issn 0002-9173, 4 p.Article

Towards a pathogenesis-oriented therapy of acute myeloid leukemia : Acute leukemiasHIDDEMANN, W; SPIEKERMANN, K; WÖRMANN, B et al.Critical reviews in oncology/hematology. 2005, Vol 56, Num 2, pp 235-245, issn 1040-8428, 11 p.Article

WT1 mutation in pediatric patients with acute myeloid leukemia: a report from the Japanese Childhood AML Cooperative Study GroupSANO, Hirozumi; SHIMADA, Akira; KOBAYASHI, Ryoji et al.International journal of hematology. 2013, Vol 98, Num 4, pp 437-445, issn 0925-5710, 9 p.Article

Hypocellular acute myeloid leukemia in adults: analysis of the clinical outcome of 123 patientsAL-KALI, Aref; KONOPLEV, Sergej; BORTHAKUR, Gautam et al.Haematologica (Roma). 2012, Vol 97, Num 2, pp 235-240, issn 0390-6078, 6 p.Article

Progress in the treatment of acute myeloid leukemiaRAVANDI, Farhad; BURNETT, Alan K; AGURA, Edward D et al.Cancer. 2007, Vol 110, Num 9, pp 1900-1910, issn 0008-543X, 11 p.Article

New agents in acute myeloid leukemia and other myeloid disordersRAVANDI, Farhad; KANTARJIAN, Hagop; GILES, Francis et al.Cancer. 2004, Vol 100, Num 3, pp 441-454, issn 0008-543X, 14 p.Article

Prognostic factors and outcome of recurrence in childhood acute myeloid leukemiaRUBNITZ, Jeffrey E; RAZZOUK, Bassem I; LENSING, Shelly et al.Cancer. 2007, Vol 109, Num 1, pp 157-163, issn 0008-543X, 7 p.Article

A G-quadruplex-interactive agent, telomestatin (SOT-095), induces telomere shortening with apoptosis and enhances chemosensitivity in acute myeloid leukemiaSUMI, M; TAUCHI, T; SASHIDA, G et al.International journal of oncology. 2004, Vol 24, Num 6, pp 1481-1487, issn 1019-6439, 7 p.Article

MEIS 1 expression is downregulated through promoter hypermethylation in AML1-ETO acute myeloid leukemiasLASA, A; CARNICER, M. J; AVENTIN, A et al.Leukemia. 2004, Vol 18, Num 7, pp 1231-1237, issn 0887-6924, 7 p.Article

Treating Octogenarian and Nonagenarian Acute Myeloid Leukemia Patients―Predictive Prognostic ModelsHARB, Antoine J; WEI TAN; WILDING, Gregory E et al.Cancer. 2009, Vol 115, Num 11, pp 2472-2481, issn 0008-543X, 10 p.Article

Deregulation of apoptosis in acute myeloid leukemiaTESTA, Ugo; RICCIONI, Roberta.Haematologica (Roma). 2007, Vol 92, Num 1, pp 81-94, issn 0390-6078, 14 p.Article

New induction and postinduction strategies in acute myeloid leukemiaBURNETT, Alan K.Current opinion in hematology. 2012, Vol 19, Num 2, pp 76-81, issn 1065-6251, 6 p.Article

Gene expression profile related to prognosis of acute myeloid leukemiaMIN HA PARK; CHO, Sun A; JONG HOON PARK et al.Oncology reports. 2007, Vol 18, Num 6, pp 1395-1402, issn 1021-335X, 8 p.Article

Molecular recognition of acute myeloid leukemia using aptamersSEFAH, K; TANG, Z. W; KIM, Y. M et al.Leukemia. 2009, Vol 23, Num 2, pp 235-244, issn 0887-6924, 10 p.Article

Acquisition of a BCR-ABL1 Transcript in a Patient with Disease Progression from MDS with Fibrosis to AML with Myelodysplasia-Related ChangesPARK, Seo-Jin; HYUN WOO LEE; SEONG HYUN JEONG et al.Annals of clinical and laboratory science. 2011, Vol 41, Num 4, pp 379-384, issn 0091-7370, 6 p.Article